Back to Results
First PageMeta Content
Malaria / Biology / Malaria vaccine / RTS / S / Crucell / Vaccination / Walter Reed Army Institute of Research / GlaxoSmithKline / Influenza vaccine / Medicine / Vaccines / Health


mvi_header_factsheet-blue
Add to Reading List

Document Date: 2011-12-27 16:13:05

Open Document

File Size: 218,30 KB

Share Result on Facebook

City

Leiden / /

Company

Merck & Co. / Johnson & Johnson / Novartis / Crucell N.V. / Pfizer / GLAXOSMITHKLINE BIOLOGICALS / Wyeth / Glaxosmithkline plc / /

Continent

Africa / /

Country

Switzerland / Netherlands / Italy / Sweden / Indonesia / Belgium / Malaysia / United States / Vietnam / Korea / United Kingdom / China / Spain / /

Event

FDA Phase / M&A / /

Facility

National Institute of Allergy / Walter Reed Army Institute of Research / /

IndustryTerm

appropriate health technologies / manufacturing sites / biopharmaceutical industry / biopharmaceutical / pharmaceuticals / manufacturing / production technology / travel vaccines / /

MedicalCondition

same malaria / only aluminum-free hepatitis A / comprehensive malaria / clinical disease / hepatitis B / malaria Malaria / Crucell’s adenovirus-based malaria / important childhood diseases / severe disease / influenza / Plasmodium falciparum malaria / malaria / highly effective malaria / infectious diseases / oral cholera / /

MedicalTreatment

immunization / immunizations / /

Organization

Walter Reed Army Institute of Research / United Nations International Children's Emergency Fund / Melinda Gates Foundation / National Institute of Allergy and Infectious Diseases / /

Position

leader / /

Product

Ad35 / RTS / /

Region

sub-Saharan Africa / /

Technology

antibodies / production technology / appropriate health technologies / /

URL

www.malariavaccine.org / www.path.org / www.crucell.com / www.gsk.com / /

SocialTag